微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 5.3% | -92.94% | 114.57% | 59/159 | 1.2% | 兴齐眼药 | 32.91% | 行业排名> |
| 2025-06-30 | 2.47% | -33.6% | 165.59% | 72/159 | 0.26% | 翰宇药业 | 18.95% | 行业排名> |
| 2025-03-31 | 0.93% | 153.45% | -74.45% | 84/159 | -0.37% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | 3.64% | 121.81% | -95.15% | 70/159 | -9.52% | 百利天恒 | 181.27% | 行业排名> |
| 2024-09-30 | 75.04% | 1591.85% | 1917.2% | 2/159 | 4.23% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 3.72% | 431.43% | 313.79% | 54/159 | 2.66% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | -1.74% | 14.71% | 89.57% | 128/159 | 2.32% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | -16.69% | 80.34% | -231.81% | 130/159 | -1.03% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | -5.03% | -115.88% | -818.57% | 127/159 | 2.34% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 0.7% | 137.43% | 134.31% | 106/159 | 1.46% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | -2.04% | -151.85% | 97.6% | 127/159 | 1.37% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | -84.91% | -6436.57% | -3544.21% | 147/159 | 0.67% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | -2.33% | -219.49% | -24.6% | 117/159 | 2.8% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | -1.87% | -279.81% | -130.86% | 122/159 | 2.16% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | -0.81% | -127.46% | -160.45% | 120/159 | 1.57% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 1.34% | -95.71% | -31.28% | 101/159 | 0.75% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | 1.95% | -95.7% | 87.5% | 106/159 | 4.43% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 1.04% | -95.32% | -64.75% | 108/159 | 2.94% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 2.95% | -39.3% | -90.56% | 44/159 | 2.49% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 31.24% | 2% | -31.07% | 3/159 | 3.58% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 45.32% | 13633.33% | 104.05% | 1/159 | 3.03% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 22.21% | -59.05% | 357% | 3/159 | 4.19% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | 4.86% | 2% | 2% | 14/159 | 2.19% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-03-31 | 0% | 100% | 2% | 101/159 | 2.41% | 誉衡药业 | 35.56% | 行业排名> |
| 2018-12-31 | 0% | 100% | -100% | 118/159 | 6.99% | 奥赛康 | 35% | 行业排名> |
| 2017-09-30 | 0.33% | 100.19% | -99.39% | 94/159 | 8.29% | 奥赛康 | 28.15% | 行业排名> |
| 2017-06-30 | 54.24% | 149.41% | 4942.86% | 1/159 | 5.58% | 宏源药业 | 21.91% | 行业排名> |
| 2017-03-31 | -1.12% | -105.81% | 99.78% | 84/159 | 2.09% | 奥赛康 | 9.7% | 行业排名> |
| 2016-12-31 | -504.73% | -743.47% | -188.09% | 112/159 | 6.19% | 奥赛康 | 40.69% | 行业排名> |
| 2016-09-30 | -175.2% | -477.84% | -59.59% | 81/159 | 5.61% | 信立泰 | 25.93% | 行业排名> |
| 2016-06-30 | -109.78% | -716.82% | -669.1% | 90/159 | 3.48% | 昂利康 | 15.91% | 行业排名> |
| 2016-03-31 | 19.29% | 355.84% | 132.24% | 1/159 | 2.65% | 奥赛康 | 12.08% | 行业排名> |
| 2015-12-31 | -59.84% | 6.24% | -97.36% | 103/159 | 11.27% | 一品红 | 31.62% | 行业排名> |
| 2015-09-30 | -30.32% | -391.82% | -125.6% | 78/159 | 7.22% | 丽珠集团 | 49.43% | 行业排名> |
| 2015-06-30 | -13.44% | 49.13% | -78.25% | 82/159 | 4.87% | 河化股份 | 54.24% | 行业排名> |
| 2015-03-31 | -7.54% | 4.8% | 88.19% | 75/159 | 2.41% | 华东医药 | 7.2% | 行业排名> |